Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Rovadicitinib in Patients with Hemophagocytic Lymphohistiocytosis: A Single Arm, Open-Label, Phase I Study

Zhao Wang, Jingshi Wang, Lin Wu, Deli Song, Yubo Pi, Dawei Ding, Yao Chen, Xunqiang Wang

Blood (2024) 144 (Supplement 1): 806.

https://doi.org/10.1182/blood-2024-203214

Published: 2024

Journal Articles

Rovadicitinib in Patients with Myelofibrosis Who Were Refractory or Relapsed or Intolerant to Ruxolitinib: A Single Arm, Multicenter, Open-Label, Phase Ib Study

Chunkang Chang, Min Zhang, Sujun Gao, Luxi Song, Duoer Wu, Dawei Ding, Shanli Lao, Ding Yu

Blood (2024) 144 (Supplement 1): 484.

https://doi.org/10.1182/blood-2024-203242

Published: 2024

Journal Articles

TQB2223 in Combination with Penpulimab in Patients with Relapsed or Refractory Lymphoma: Primary Analysis of an Open-Label Phase I Study

Qingqing Cai, Yi Xia, Xiaojie Fang, Man Nie, Qihua Zou, Jun Cai, Yuchen Zhang, Qiuyi Yang, Dawei Ding, Wen Wang, Xunqiang Wang

Blood (2024) 144 (Supplement 1): 3047.

https://doi.org/10.1182/blood-2024-203156

Published: 2024

Journal Articles

First-in-Class JAK/Rock Inhibitor Rovadicitinib in Myeloproliferative Neoplasms: A Single Arm, Multicenter, Open-Label, Phase I/Ib Study

Zefeng Xu, Ling Pan, Zhenya Hong, Qingsong Yin, Xuelan Zuo, Qin Wen, Fan Yu, Chunkang Chang, Wei Ling, Dong Wang, Dawei Ding, Zhijian Xiao

Blood (2023) 142 (Supplement 1): 1829.

https://doi.org/10.1182/blood-2023-178956

Published: 2023